Does cDC20 overexpression predict a poor prognosis for patients with colorectal cancer?
CDC20 may serve as a potential prognostic biomarker of human colorectal cancer.
AFI endoscopy may reliably determine the depth of gastric cancer tumor invasion, although an expanded study comprised of larger numbers of subjects and different types of cancers may be required to clearly demonstrate its validity.